{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:51:33Z","timestamp":1781945493335,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jad.2026.121208","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:38:23Z","timestamp":1769013503000},"page":"121208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational study"],"prefix":"10.1016","volume":"400","author":[{"given":"Jan","family":"Sarlon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanne","family":"Thomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette B.","family":"Br\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timur","family":"Liwinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121208_bb0005","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/bcp.13280","article-title":"Defining the noninferiority margin and analysing noninferiority: an overview","volume":"83","author":"Althunian","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.121208_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.648691","article-title":"Intranasal ketamine for depression in adults: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"12","author":"An","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.121208_bb0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121208_bb0020","first-page":"340","article-title":"Intranasal esketamine (SpravatoTM) for use in treatment-resistant depression in conjunction with an oral antidepressant","volume":"44","author":"Bahr","year":"2019","journal-title":"P T"},{"key":"10.1016\/j.jad.2026.121208_bb0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121208_bb0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0706743719828965","article-title":"Current and common definitions of treatment-resistant depression: findings from a systematic review and qualitative interviews","volume":"64","author":"Brown","year":"2019","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.121208_bb0035","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/JCP.0000000000001465","article-title":"Esketamine nasal spray for the rapid reduction of depressive symptoms in major depressive disorder with acute suicidal ideation or behavior","volume":"41","author":"Canuso","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121208_bb0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jad.2023.12.038","article-title":"The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: a post-hoc analysis of pooled real-world data","volume":"348","author":"d\u2019Andrea","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121208_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression","volume":"67","author":"Dunner","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121208_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose Esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.121208_bb0055","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2026.121208_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/da.22968","article-title":"Defining treatment-resistant depression","volume":"37","author":"Gaynes","year":"2020","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2026.121208_bb0065","article-title":"Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety","volume":"15","author":"Hauser","year":"2024","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.121208_bb0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jad.2026.121208_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2026.121208_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2015.17.2\/dionescu","article-title":"Pharmacological approaches to the challenge of treatment-resistant depression","volume":"17","author":"Ionescu","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.121208_bb0090","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1185\/03007995.2010.517716","article-title":"Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder","volume":"26","author":"Ivanova","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2026.121208_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.105279","article-title":"Efficacy and safety of esketamine nasal spray as monotherapy in adults with treatment-resistant depression: a randomized, double-blind, placebo-controlled study","volume":"3","author":"Janik","year":"2024","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.jad.2026.121208_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25531","article-title":"Magnitude of the placebo response across treatment modalities used for treatment-resistant depression in adults","volume":"4","author":"Jones","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2026.121208_bb0105","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/biomedicines12102283","article-title":"Ketamine, esketamine, and arketamine: their mechanisms of action and applications in the treatment of depression and alleviation of depressive symptoms","volume":"12","author":"Kawczak","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jad.2026.121208_bb0110","first-page":"524","article-title":"Can prefrontal theta cordance differentiate between depression recovery and dissimulation?","volume":"28","author":"Kopecek","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jad.2026.121208_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/13651501.2016.1254802","article-title":"Administration of ketamine for unipolar and bipolar depression","volume":"21","author":"Kraus","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.jad.2026.121208_bb0120","first-page":"1365","article-title":"Emulating a randomised controlled trial with observational data: an introduction to the target trial framework","volume":"37","author":"Kutcher","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jad.2026.121208_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2013.03.013","article-title":"Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: a 12-month, double-blind, noninferiority study","volume":"147","author":"Loebel","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2026.121208_bb0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2022.09.043","article-title":"Real-world experience of esketamine use to manage treatment-resistant depression: a multicentric study on safety and effectiveness (REAL-ESK study)","volume":"319","author":"Martinotti","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121208_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jad.2021.09.046","article-title":"What is the short-term remission rate for people with untreated depression? A systematic review and meta-analysis","volume":"296","author":"Mekonen","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121208_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172547","article-title":"Ketamine applications beyond anesthesia \u2013 a literature review","volume":"860","author":"Nowacka","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2026.121208_bb0145","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.clinthera.2024.06.017","article-title":"Balancing evidence and need: variation in US commercial payer coverage of esketamine","volume":"46","author":"Ochigbo","year":"2024","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2026.121208_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121208_bb0155","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/appi.ps.201900625","article-title":"Cost-effectiveness of esketamine nasal spray for patients with treatment-resistant depression in the United States","volume":"71","author":"Ross","year":"2020","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2026.121208_bb0160","article-title":"Intranasal racemic ketamine in treatment-resistant depression: efficacy and tolerability in outpatient treatment","volume":"21","author":"Sarlon","year":"2025","journal-title":"J. Affect. Disord. Rep."},{"issue":"2","key":"10.1016\/j.jad.2026.121208_bb9000","first-page":"51","article-title":"Untersuchungen zur reliabilit\u00e4t und validit\u00e4t einer deutschen version der montgomery-asberg depression-rating scale (MADRS) [Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)]","volume":"139","author":"Schmidtke","year":"1988","journal-title":"Schweiz Arch. Neurol. Psychiatr. (1985)"},{"key":"10.1016\/j.jad.2026.121208_bb0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/00223891003670232","article-title":"Development and psychometric characteristics of the dissociation tension scale","volume":"92","author":"Stiglmayr","year":"2010","journal-title":"J. Pers. Assess."},{"key":"10.1016\/j.jad.2026.121208_bb0170","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121208_bb0175","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2026.121208_bb0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpsychires.2024.07.054","article-title":"Change in the global burden of depression from 1990-2019 and its prediction for 2030","volume":"178","author":"Zhang","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121208_bb0185","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121208_bb0190","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1037\/pha0000437","article-title":"Compounded intranasal racemic ketamine for major depressive disorder: a case report","volume":"29","author":"Ziegler","year":"2021","journal-title":"Exp. Clin. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:25:00Z","timestamp":1781943900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S0165032726000595"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121208","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121208"}}